{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:14:06Z","timestamp":1773342846410,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.7759\/cureus.105087","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:09:36Z","timestamp":1773310176000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Neutrophil-to-Lymphocyte Ratio With Early Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Geetika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneeta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunny","family":"Babber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000210","article-title":"Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data","volume":"9","author":"Heald AH","year":"2020","unstructured":"Heald AH, Stedman M, Davies M, et al.. Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data. Cardiovasc Endocrinol Metab. 2020, 9:183-5. 10.1097\/XCE.0000000000000210","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole JB","year":"2020","unstructured":"Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020, 16:377-90. 10.1038\/s41581-020-0278-5","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun H","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al.. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022, 183:109119. 10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref4","article-title":"Diabetic nephropathy","author":"Rout P","year":"2026","unstructured":"Rout P, Jialal I. Diabetic nephropathy. StatPearls. StatPearls Publishing, Treasure Island, FL; 2026."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-196","article-title":"U.S. Centers for Disease Control and Prevention launches new chronic kidney disease surveillance system website","volume":"14","author":"Johns T","year":"2013","unstructured":"Johns T, Jaar BG. U.S. Centers for Disease Control and Prevention launches new chronic kidney disease surveillance system website. BMC Nephrol. 2013, 14:196. 10.1186\/1471-2369-14-196","journal-title":"BMC Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris S","year":"2019","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, et al.. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019, 14:50-9. 10.15420\/ecr.2018.33.1","journal-title":"Eur Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.6026\/97320630019375","article-title":"Role of neutrophil-lymphocyte ratio as a prognostic marker for type 2 diabetic nephropathy among Indians","volume":"19","author":"Subramani M","year":"2023","unstructured":"Subramani M, Anbarasan M, Shanmugam D, Muthumani LN, Vasudevan P. Role of neutrophil-lymphocyte ratio as a prognostic marker for type 2 diabetic nephropathy among Indians. Bioinformation. 2023, 19:375-9. 10.6026\/97320630019375","journal-title":"Bioinformation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.0264","article-title":"Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes","volume":"16","author":"Shiny A","year":"2014","unstructured":"Shiny A, Bibin YS, Shanthirani CS, et al.. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014, 16:524-30. 10.1089\/dia.2013.0264","journal-title":"Diabetes Technol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.04.046","article-title":"Association of glycemic status and interferon-\u03b3 production with leukocytes and platelet indices alterations in type 2 diabetes","volume":"13","author":"Abdel-Moneim A","year":"2019","unstructured":"Abdel-Moneim A, Semmler M, Abdel-Reheim ES, Zanaty MI, Addaleel W. Association of glycemic status and interferon-\u03b3 production with leukocytes and platelet indices alterations in type 2 diabetes. Diabetes Metab Syndr. 2019, 13:1963-9. 10.1016\/j.dsx.2019.04.046","journal-title":"Diabetes Metab Syndr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2019.20139","article-title":"Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus","volume":"149","author":"Kocak MZ","year":"2019","unstructured":"Kocak MZ, Aktas G, Erkus E, Yis OM, Duman TT, Atak BM, Savli H. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019, 149:w20139. 10.4414\/smw.2019.20139","journal-title":"Swiss Med Wkly"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson SE","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006, 116:1793-801. 10.1172\/JCI29069","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup JC","year":"2004","unstructured":"Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004, 27:813-23. 10.2337\/diacare.27.3.813","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051218","article-title":"Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones","volume":"42","author":"Tanaka T","year":"1999","unstructured":"Tanaka T, Itoh H, Doi K, et al.. Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia. 1999, 42:702-10. 10.1007\/s001250051218","journal-title":"Diabetologia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019, 42:S61-70. 10.2337\/dc19-S006","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2007.s79","article-title":"Nephropathy in diabetes","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004, 27:S79-83. 10.2337\/diacare.27.2007.s79","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvab278","article-title":"National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories","volume":"68","author":"Miller WG","year":"2022","unstructured":"Miller WG, Kaufman HW, Levey AS, et al.. National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories. Clin Chem. 2022, 68:511-20. 10.1093\/clinchem\/hvab278","journal-title":"Clin Chem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) Diabetes Work Group: KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022, 102:S1-127. 10.1016\/j.kint.2022.06.008","journal-title":"Kidney Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer IH","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, et al.. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022, 45:3075-90. 10.2337\/dci22-0027","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9841-8_1","article-title":"Diabetic nephropathy: an overview","volume":"2067","author":"Sagoo MK","year":"2020","unstructured":"Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Methods Mol Biol. 2020, 2067:3-7. 10.1007\/978-1-4939-9841-8_1","journal-title":"Methods Mol Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74","volume":"55","author":"Retnakaran R","year":"2006","unstructured":"Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006, 55:1832-9. 10.2337\/db05-1620","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid M","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022, 12:542. 10.3390\/biom12040542","journal-title":"Biomolecules"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/146154","article-title":"Inflammation in diabetic nephropathy","volume":"2012","author":"Lim AK","year":"2012","unstructured":"Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm. 2012, 2012:146154. 10.1155\/2012\/146154","journal-title":"Mediators Inflamm"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_476_16","article-title":"Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes","volume":"21","author":"Khandare SA","year":"2017","unstructured":"Khandare SA, Chittawar S, Nahar N, Dubey TN, Qureshi Z. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian J Endocrinol Metab. 2017, 21:387-92. 10.4103\/ijem.IJEM_476_16","journal-title":"Indian J Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09734-x","article-title":"Investigating the relationship between lymphocyte cells apoptosis and DNA damage and oxidative stress and therapeutic and clinical outcomes of COVID-19 elderly patients","volume":"24","author":"Abiri E","year":"2024","unstructured":"Abiri E, Mirzaii M, Moghbeli M, Atashi A, Harati AA. Investigating the relationship between lymphocyte cells apoptosis and DNA damage and oxidative stress and therapeutic and clinical outcomes of COVID-19 elderly patients. BMC Infect Dis. 2024, 24:940. 10.1186\/s12879-024-09734-x","journal-title":"BMC Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12576","article-title":"Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy","volume":"82","author":"Huang W","year":"2015","unstructured":"Huang W, Huang J, Liu Q, Lin F, He Z, Zeng Z, He L. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol (Oxf). 2015, 82:229-33. 10.1111\/cen.12576","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2012.668741","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study)","volume":"34","author":"Azab B","year":"2012","unstructured":"Azab B, Daoud J, Naeem FB, et al.. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail. 2012, 34:571-6. 10.3109\/0886022X.2012.668741","journal-title":"Ren Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_197_17","article-title":"Neutrophil-lymphocyte ratio is a novel reliable predictor of nephropathy, retinopathy, and coronary artery disease in Indians with type-2 diabetes","volume":"21","author":"Chittawar S","year":"2017","unstructured":"Chittawar S, Dutta D, Qureshi Z, Surana V, Khandare S, Dubey TN. Neutrophil-lymphocyte ratio is a novel reliable predictor of nephropathy, retinopathy, and coronary artery disease in Indians with type-2 diabetes. Indian J Endocrinol Metab. 2017, 21:864-70. 10.4103\/ijem.IJEM_197_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/20503121221140231","article-title":"Neutrophil-lymphocyte ratio as an inflammatory biomarker of diabetic nephropathy among type 2 diabetes mellitus patients: a comparative cross-sectional study","volume":"10","author":"Gurmu MZ","year":"2022","unstructured":"Gurmu MZ, Genet S, Gizaw ST, Feyisa TO, Gnanasekaran N. Neutrophil-lymphocyte ratio as an inflammatory biomarker of diabetic nephropathy among type 2 diabetes mellitus patients: a comparative cross-sectional study. SAGE Open Med. 2022, 10:10.1177\/20503121221140231","journal-title":"SAGE Open Med"},{"key":"ref29","article-title":"The relationship between neutrophil\/lymphocyte ratio, albuminuria and renal dysfunction in diabetic nephropathy","volume":"19","author":"Gupta N","year":"2018","unstructured":"Gupta N, Karoli R, Singh PS, Shrivastava A. The relationship between neutrophil\/lymphocyte ratio, albuminuria and renal dysfunction in diabetic nephropathy. J Indian Acad Clin Med. 2018, 19:265-8.","journal-title":"J Indian Acad Clin Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-023-06234-z","article-title":"Exploring systemic inflammation in children with chronic kidney disease: correlates of interleukin 6","volume":"39","author":"Karava V","year":"2024","unstructured":"Karava V, Kondou A, Dotis J, Taparkou A, Farmaki E, Kollios K, Printza N. Exploring systemic inflammation in children with chronic kidney disease: correlates of interleukin 6. Pediatr Nephrol. 2024, 39:1567-76. 10.1007\/s00467-023-06234-z","journal-title":"Pediatr Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2012.734429","article-title":"Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease","volume":"35","author":"Okyay GU","year":"2013","unstructured":"Okyay GU, Inal S, One\u00e7 K, et al.. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013, 35:29-36. 10.3109\/0886022X.2012.734429","journal-title":"Ren Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459805-association-of-neutrophil-to-lymphocyte-ratio-with-early-diabetic-nephropathy-in-patients-with-type-2-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:09:37Z","timestamp":1773310177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459805-association-of-neutrophil-to-lymphocyte-ratio-with-early-diabetic-nephropathy-in-patients-with-type-2-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.105087","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}